Assessing bradykinesia in parkinsonian disorders

Area of Science:

• Neurology
• Movement Disorders
• Biomedical Engineering

Background:

• Bradykinesia is a hallmark symptom of Parkinson's disease (PD) and atypical Parkinsonian syndromes.
• Accurate measurement of bradykinesia is essential for diagnosis and management.
• Existing assessment tools include clinical rating scales and technology-based methods.

Purpose of the Study:

• To review and analyze the reliability and applicability of existing tools for measuring bradykinesia.
• To compare the utility of clinical rating scales and technology-based assessments in PD and atypical Parkinsonian syndromes.

Main Methods:

• Summarized data on the factor structure of the Unified Parkinson's Disease Rating Scale (UPDRS) and the Movement Disorder Society revision of the UPDRS (MDS-UPDRS).
• Reviewed the application of these scales in atypical Parkinsonian syndromes, specifically Progressive Supranuclear Palsy (PSP).
• Reported on various technology-based tools used for bradykinesia assessment.

Main Results:

• The UPDRS and MDS-UPDRS demonstrate high reliability and applicability for assessing bradykinesia in PD.
• The UPDRS is also applicable for assessing bradykinesia in PSP.
• Technology-based tools (e.g., gyrosensors, motion analysis systems) are effective in measuring bradykinesia and comparable to the UPDRS motor subscale.

Conclusions:

• The UPDRS and MDS-UPDRS are well-established, reliable, and applicable measures for bradykinesia in PD and PSP.
• Various technology-based tools show effectiveness in bradykinesia assessment.
• Further validation and clinical integration of technology-based tools are needed.